Immune repons induced by vaccination with BCG
Completed
- Conditions
- Immuunresponse by BCG vaccination Tuberculosis10028440
- Registration Number
- NL-OMON37373
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
Healthy;Age 18-55 year;Naieve Tuberculose volunteers (negative TST and negative QFN-test)
Exclusion Criteria
History of TB disease or treatment;BCG vaccination;HIV-positive;Pregnancy / breastfeeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Vaccine induced changes in the antigen-specific immune response and in<br /><br>BCG-specific biomarkers following vaccination with BCG.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does BCG vaccination modulate in tuberculosis immune responses?
How does BCG vaccination compare to standard-of-care in tuberculosis prevention and treatment?
Which biomarkers correlate with enhanced immune response following BCG vaccination?
What are the potential adverse events associated with BCG vaccination in tuberculosis patients?
Are there combination therapies with BCG for tuberculosis that show improved efficacy?